A Tool for Deprescribing Antithrombotic Medication in Palliative Cancer Patients: A Retrospective Evaluation

References

• Lindsay J, Dooley M, Martin J, Fay M, Kearney A, Barras M. Reducing potentially inappropriate medications in palliative cancer patients: evidence to support deprescribing approaches. Support Care Cancer. 2014;22(4):1113–9. doi:10.1007/s00520-013-2098-7.
   PubMed Web of Science ®Google Scholar
• Karuturi MS, Holmes HM, Lei X, Johnson M, Barcenas CH, Cantor SB, Gallick GE, Bast RC, Giordano SH. Potentially inappropriate medications defined by STOPP criteria in older patients with breast and colorectal cancer. J Geriatr Oncol. 2019;10(5):705–8. doi:10.1016/j.jgo.2019.01.024.
   PubMed Web of Science ®Google Scholar
• Miller MG, Kneuss TG, Patel JN, Parala-Metz AG, Haggstrom DE. Identifying potentially inappropriate medication (PIM) use in geriatric oncology. J Geriatr Oncol. 2021;12(1):34–40. doi:10.1016/j.jgo.2020.06.013.
   PubMed Web of Science ®Google Scholar
• Morin L, Todd A, Barclay S, Wastesson JW, Fastbom J, Johnell K. Preventive drugs in the last year of life of older adults with cancer: is there room for deprescribing? Cancer. 2019;125(13):2309–17. doi:10.1002/cncr.32044.
   PubMed Web of Science ®Google Scholar
• Huisman BAA, Geijteman ECT, Arevalo JJ, Dees MK, van Zuylen L, Szadek KM, van der Heide A, Steegers MAH. Use of antithrombotics at the end of life: an in-depth chart review study. BMC Palliat Care. 2021;20(1):110. doi:10.1186/s12904-021-00786-3.
   PubMed Web of Science ®Google Scholar
• Huisman BAA, Geijteman ECT, Kolf N, Dees MK, Van Zuylen L, Szadek KM, Steegers MAH, van der Heide A. Physicians’ opinions on anticoagulant therapy in patients with a limited life expectancy. Semin Thromb Hemost. 2021;47(6):735–44. doi:10.1055/s-0041-1725115.
   PubMedGoogle Scholar
• Agnelli G, Becattini C. Treatment of DVT: how long is enough and how do you predict recurrence. J Thromb Thrombolysis. 2008;25(1):37–44. doi:10.1007/s11239-007-0103-z.
   PubMed Web of Science ®Google Scholar
• Prandoni P, Lensing AWA, Piccioli A, Bernardi E, Simioni P, Girolami B, Marchiori A, Sabbion P, Prins MH, Noventa F, et al. Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis. Blood. 2002;100(10):3484–8. doi:10.1182/blood-2002-01-0108.
   PubMed Web of Science ®Google Scholar
• Heit JA, Silverstein MD, Mohr DN, Petterson TM, O’Fallon WM, Melton LJ. Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. Arch Intern Med. 2002;160(6):809–15. doi:10.1001/archinte.160.6.809.
   Google Scholar
• Lindsay J, Dooley M, Martin J, Fay M, Kearney A, Khatun M, Barras M. The development and evaluation of an oncological palliative care deprescribing guideline: the OncPal deprescribing guideline. Support Care Cancer. 2015;23(1):71–8. doi:10.1007/s00520-014-2322-0.
   PubMed Web of Science ®Google Scholar
• Lavan AH, Gallagher P, Parsons C, O’Mahony D. STOPPFrail (Screening Tool of Older Persons Prescriptions in Frail adults with limited life expectancy): consensus validation. Age Ageing. 2017;46(4):600–7. doi:10.1093/ageing/afx005.
   PubMed Web of Science ®Google Scholar
• van Merendonk LN, Crul M. Deprescribing in palliative patients with cancer: a concise review of tools and guidelines. Support Care Cancer. 2022;30(4):2933–43. doi:10.1007/s00520-021-06605-y.
   PubMed Web of Science ®Google Scholar
• Huisman BAA. Optimizing care at the end of life: decision-making on medication with an emphasis on antithrombotics. PhD thesis. Vrije Universiteit Amsterdam. 2022. ISBN 9789464236927.
   Google Scholar
• Lip GYH, Nieuwlaat R, Pisters R, Lane DA, Crijns HJGM. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on atrial fibrillation. Chest. 2010;137(2):263–72. doi:10.1378/chest.09-1584.
   PubMed Web of Science ®Google Scholar
• Pisters R, Lane DA, Nieuwlaat R, De Vos CB, Crijns HJGM, Lip GYH. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the euro heart survey. Chest. 2010;138(5):1093–100. doi:10.1378/chest.10-0134.
   PubMed Web of Science ®Google Scholar
• Bateman RM, Sharpe MD, Jagger JE, Ellis CG, Solé-Violán J, López-Rodríguez M, Herrera-Ramos E, Ruíz-Hernández J, Borderías L, Horcajada J, González-Quevedo N. Chronic kidney disease: national clinical guideline for early identification and management in adults in primary and secondary care. Crit Care.2008;20(Suppl 2):94.
   Google Scholar
• Khan F, Tritschler T, Kahn SR, Rodger MA. Venous thromboembolism. Lancet. 2021;398(10294):64–77. doi:10.1016/S0140-6736(20)32658-1.
   PubMed Web of Science ®Google Scholar
• Boon GJAM, Van Dam LF, Klok FA, Huisman MV. Management and treatment of deep vein thrombosis in special populations. Expert Rev Hematol. 2018;11(9):685–95. doi:10.1080/17474086.2018.1502082.
   PubMed Web of Science ®Google Scholar
• Oliveira L, Ferreira MO, Rola A, Magalhães M, Ferraz Gonçalves J. Deprescription in advanced cancer patients referred to palliative care. J Pain Palliat Care Pharmacother. 2016;30(3):201–5. doi:10.1080/15360288.2016.1204411.
   PubMed Web of Science ®Google Scholar
• Noel-Savina E, Sanchez O, Descourt R, André M, Leroyer C, Meyer G, Couturaud F. Tinzaparin and VKA use in patients with cancer associated venous thromboembolism: a retrospective cohort study. Thromb Res. 2015;135(1):78–83. doi:10.1016/j.thromres.2014.10.030.
   PubMed Web of Science ®Google Scholar
• Integraal Kanker Centrum Nederland (IKNL) Code N. Tumorindeling. 2022. Available from: https://iknl.nl/nkr/registratie/tumorindeling. Accessed September 2022.
   Google Scholar
• Schulman S, Kearon C, Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost. 2005;3(4):692–4. doi:10.1111/j.1538-7836.2005.01204.x.
   PubMed Web of Science ®Google Scholar